Walter Reed, PATH to test modified regimen of GlaxoSmithKline’s Mosquirix
admin 11th September 2017 Uncategorised 0GlaxoSmithKline’s RTS,S malaria vaccine, also known as Mosquirix, is set to undergo a pilot real-world study among infants in three African countries, just as PATH and the U.S. Army researchers are trying to determine if modifications to the vaccine regimen could provide better protection.
More: Walter Reed, PATH to test modified regimen of GlaxoSmithKline’s Mosquirix
Source: fierce